Methamphetamine-induced changes in the mice hippocampal neuropeptide y system: Implications for memory impairment

Journal of Neurochemistry

Volumn 123, Issue 6, 2012, Pages 1041-1053

  Gonçalves, Joana ^a   Baptista, Sofia ^a   Olesen, Mikkel V ^b   Fontes Ribeiro, Carlos ^a   Malva, João O ^a,c   Woldbye, David P ^b   Silva, Ana P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

AKT mTOR pathway; hippocampus; memory; methamphetamine; neuropeptide Y; Y 2 receptor

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METHAMPHETAMINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PROTEIN KINASE B;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HIPPOCAMPAL CA1 REGION; INTRACELLULAR SIGNALING; MALE; MEMORY; MEMORY DISORDER; METHAMPHETAMINE DEPENDENCE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; HIPPOCAMPUS; MALE; MEMORY DISORDERS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

MAMMALIA; MUS;

EID: 84870604235     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12052     Document Type: Article

References (81)

1. Belcher A. M., O'Dell S. J., and, Marshall J. F., (2005) Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30, 2026-2034.
2. Belcher A. M., Feinstein E. M., O'Dell S. J., and, Marshall J. F., (2008) Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33, 1453-1463.
3. Berglund M. M., Hipskind P. A., and, Gehlert D. R., (2003) Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. 228, 217-244.
4. Bliss T. V., and, Collingridge G. L., (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
5. Broadbent N. J., Squire L. R., and, Clark R. E., (2004) Spatial memory, recognition memory, and the hippocampus. Proc. Natl Acad. Sci. USA 101, 14515-14520.
6. Bruel-Jungerman E., Davis S., and, Laroche S., (2007) Brain plasticity mechanisms and memory: a party of four. Neuroscientist 13, 492-505.
7. Bura S. A., Castañé A., Ledent C., Valverde O., and, Maldonado R., (2007) Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes. Br. J. Pharmacol. 150, 758-765.
8. Cadet J. L., and, Krasnova I. N., (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int. Rev. Neurobiol. 88, 101-119.
9. Cammalleri M., Lütjens R., Berton F., King A. R., Simpson C., Francesconi W., and, Sanna P. P., (2003) Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 14368-14373.
10. Cannizzarro C., Tel B. C., Rose S., Zeng B. Y., and, Jenner P., (2003) Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease. Brain Res. Mol. Brain Res. 110, 169-176.
11. Chen W. S., Xu P. Z., Gottlob K., et al,. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208.
12. Cherng C. G., Tsai C. W., Tsai Y. P., Ho M. C., Kao S. F., and, Yu L., (2007) Methamphetamine-disrupted sensory processing mediates conditioned place preference performance. Behav. Brain Res. 182, 103-108.
13. 35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J. Neurosci. Res. 84, 1282-1291.
14. Cook C. E., Jeffcoat A. R., Hill J. M., Pugh D. E., Patetta P. K., Sadler B. M., White W. R., and, Perez-Reyes M., (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab. Dispos. 21, 717-723.
15. Costa-Mattioli M., Sossin W. S., Klann E., and, Sonenberg N., (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron 61, 10-26.
16. Decressac M., Wright B., David B., Tyers P., Jaber M., Barker R. A., and, Gaillard A., (2010) Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 21, 233-238.
17. Dumont Y., Cadieux A., Doods H., Pheng L. H., Abounader R., Hamel E., Jacques D., Regoli D., and, Quirion R., (2000) BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br. J. Pharmacol. 129, 1075-1088.
18. Duszczyk M., Ziembowicz A., Gadamski R., Wieronska J. M., Smialowska M., and, Lazarewicz J. W., (2009) Changes in the NPY immunoreactivity in gerbil hippocampus after hypoxia and ischemic preconditioning. Neuropeptides 43, 31-39.
19. Easton R. M., Cho H., Roovers K., et al,. (2005) Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 25, 1869-1878.
20. Frankland P. W., and, Bontempi B., (2005) The organization of recent and remote memories. Nat. Rev. Neurosci. 6, 119-130.
21. Gehlert D. R., (2004) Introduction to the reviews on neuropeptide Y. Neuropeptides 38, 135-140.
22. Gonçalves J., Martins T., Ferreira R., Milhazes N., Borges F., Ribeiro C. F., Malva J. O., Macedo T. R., and, Silva A. P., (2008) Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N. Y. Acad. Sci. 1139, 103-111.
23. Gonçalves J., Baptista S., Martins T., Milhazes N., Borges F., Ribeiro C. F., Malva J. O., and, Silva A. P., (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci. 31, 315-326.
24. Goodman J. H., and, Slovitter R. S., (1993) Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus; a silver degeneration and immunocytochemistry study. Brain Res. 616, 263-272.
25. Gøtzsche C. R., Nikitidou L., Sørensen A. T., Olesen M. V., Sørensen G., Christiansen S. H., Angehagen M., Woldbye D. P., and, Kokaia M., (2012) Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures. Neurobiol. Dis. 45, 288-296.
26. Hoeffer C. A., and, Klann E., (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75.
27. Hori N., Kadota M. T., Watanabe M., Ito Y., Akaike N., and, Carpenter D. O., (2010) Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons. Cell. Mol. Neurobiol. 30, 849-856.
28. Horner K. A., Westwood S. C., Hanson G. R., and, Keefe K. A., (2006) Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism. J. Pharmacol. Exp. Ther. 319, 414-421.
29. Kandel E. R., (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038.
30. Karl T., Duffy L., and, Herzog H., (2008) Behavioural profile of a new mouse model for NPY deficiency. Eur. J. Neurosci. 28, 173-180.
31. Krasnova I. N., and, Cadet J. L., (2009) Methamphetamine toxicity and messengers of death. Brain Res. Rev. 60, 379-407.
32. Lee K. W., Kim H. C., Lee S. Y., and, Jang C. G., (2011) Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus. Neuroscience 178, 101-107.
33. Marshall J. F., and, O'Dell S. J., (2012) Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci. 35, 536-545.
34. Martins T., Baptista S., Gonçalves J., et al,. (2011) Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: Role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 1411, 28-40.
35. Meurs A., Clinckers R., Ebinger G., Michotte Y., and, Smolders I., (2007) Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Eur. J. Neurosci. 26, 3079-3092.
36. Naveilhan P., Neveu I., Arenas E., and, Ernfors P., (1998) Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 87, 289-302.
37. Neves G., Cooke S. F., and, Bliss T. V., (2008) Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9, 65-75.
38. O'Dell S. J., Feinberg L. M., and, Marshall J. F., (2011) A neurotoxic regimen of methamphetamine impairs novelty recognition as measured by a social odor-based task. Behav. Brain Res. 216, 396-401.
39. Olesen M. V., Christiansen S. H., Gøtzsche C. R., Nikitidou L., Kokaia M., and, Woldbye D. P., (2012) Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. J. Neurosci. Res. 90, 498-507.
40. Olling J. D., Ulrichsen J., Christensen D. Z., and, Woldbye D. P., (2009) Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain. J. Neurosci. Res. 87, 2386-2397.
41. Opazo P., Watabe A. M., Grant S. G., and, O'Dell T. J., (2003) Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J. Neurosci. 23, 3679-3688.
42. Paxinos G., and, Franklin K. B. J., (2004) The Mouse Brain in Stereotaxic Coordinates: Compact Second Edition. San Diego, CA, Elsevier Academic Press.
43. Raudensky J., and, Yamamoto B. K., (2007) Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Res. 1135, 129-135.
44. Redrobe J. P., Dumont Y., Fournier A., and, Quirion R., (2002) The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26, 615-624.
45. Reichel C. M., Schwendt M., McGinty J. F., Olive M. F., and, See R. E., (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36, 782-792.
46. Reichel C. M., Ramsey L. A., Schwendt M., McGinty J. F., and, See R. E., (2012) Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62, 1119-1126.
47. Rimondini R., Thorsell A., and, Heilig M., (2005) Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci. Lett. 375, 129-133.
48. Salo R., Ursu S., Buonocore M. H., Leamon M. H., and, Carter C., (2009) Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study. Biol. Psychiatry 65, 706-709.
49. Schroeder J. P., Iller K. A., and, Hodge C. W., (2003) Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration. Alcohol. Clin. Exp. Res. 27, 1912-1920.
50. Schwarzer C., and, Sperk G., (1998) Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors. Hippocampus 8, 274-288.
51. Scott J. C., Woods S. P., Matt G. E., Meyer R. A., Heaton R. K., Atkinson J. H., and, Grant I., (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17, 275-297.
52. Silva A. P., Carvalho A. P., Carvalho C. M., and, Malva J. O., (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 79, 286-296.
53. Silva A. P., Pinheiro P. S., Carvalho A. P., Carvalho C. M., Jakobsen B., Zimmer J., and, Malva J. O., (2003a) Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J. 17, 1118-1120.
54. Silva A. P., Carvalho A. P., Carvalho C. M., and, Malva J. O., (2003b) Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44, 282-292.
55. Silva A. P., Xapelli S., Pinheiro P. S., Ferreira R., Lourenço J., Cristovão A., Grouzmann E., Cavadas C., Oliveira C. R., and, Malva J. O., (2005a) Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem. 93, 163-170.
56. Silva A. P., Xapelli S., Grouzmann E., and, Cavadas C., (2005b) The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 4, 331-347.
57. Silva A. P., Lourenço J., Xapelli S., Ferreira R., Kristiansen H., Woldbye D. P., Oliveira C. R., and, Malva J. O., (2007) Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus. FASEB J. 21, 671-681.
58. Silva A. P., Martins T., Baptista S., Gonçalves J., Agasse F., and, Malva J. O., (2010) Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier. Curr. Drug Abuse Rev. 3, 239-254.
59. Simões P. F., Silva A. P., Pereira F. C., Marques E., Grade S., Milhazes N., Borges F., Ribeiro C. F., and, Macedo T. R., (2007) Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150, 433-441.
60. Sørensen A. T., Kanter-Schlifke I., Carli M., Balducci C., Noe F., During M. J., Vezzani A., and, Kokaia M., (2008a) NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus 18, 564-574.
61. Sørensen A. T., Kanter-Schlifke I., Lin E. J., During M. J., and, Kokaia M., (2008b) Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Mol. Cell. Neurosci. 39, 229-237.
62. 35S]GTPgammaS. Brain Res. Brain Res. Rev. 38, 149-164.
63. Swant J., Chirwa S., Stanwood G., and, Khoshbouei H., (2010) Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS ONE 5, e11382.
64. Takahashi H., Kato M., Takano H., et al,. (2008) Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions. J. Neurosci. 28, 12032-12038.
65. Thiele T. E., Koh M. T., and, Pedrazzini T., (2002) Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 2, RC208.
66. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S. R., Palmiter R. D., and, Cadet J. L., (2005) Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J. Neurosci. 25, 5273-5279.
67. Thompson P. M., Hayashi K. M., Simon S. L., Geaga J. A., Hong M. S., Sui Y., Lee J. Y., Toga A. W., Ling W., and, London E. D., (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24, 6028-6036.
68. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., and, Rimondini R., (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl Acad. Sci. USA 97, 12852-12857.
69. Thorsell A., Rimondini R., and, Heilig M., (2002) Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci. Lett. 332, 1-4.
70. Tulloch I. K., Afanador L., Zhu J., and, Angulo J. A., (2011) Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in mice. Curr. Neuropharmacol. 9, 79-83.
71. Vann S. D., and, Albasser M. M., (2011) Hippocampus and neocortex: recognition and spatial memory. Curr. Opin. Neurobiol. 21, 440-445.
72. Vezzani A., and, Sperk G., (2004) Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides 38, 245-252.
73. Wiltgen B. J., Zhou M., Cai Y., Balaij J., Karlsson M. G., Parivash S. N., Li W., and, Silva A. J., (2010) The hippocampus plays a selective role in the retrieval of detailed contextual memories. Curr. Biol. 20, 1336-1344.
74. Woldbye D. P., Madsen T. M., Larsen P. J., Mikkelsen J. D., and, Bolwig T. G., (1996) Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737, 162-168.
75. Woldbye D. P., Nanobashvili A., Sørensen A. T., Husum H., Bolwig T. G., Sørensen G., Ernfors P., and, Kokaia M., (2005) Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Neurobiol. Dis. 20, 760-772.
76. Woldbye D. P., Angehagen M., Gøtzsche C. R., et al,. (2010) Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures. Brain 133, 2778-2788.
77. Woulfe D., Jiang H., Morgans A., Monks R., Birnbaum M., and, Brass L. F., (2004) Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J. Clin. Invest. 113, 441-450.
78. Xapelli S., Agasse F., Ferreira R., Silva A. P., and, Malva J. O., (2006) Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Pat. CNS Drug Discov. 1, 315-324.
79. Xapelli S., Silva A. P., Ferreira R., and, Malva J. O., (2007) Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides 28, 288-294.
80. Zambello E., Zanetti L., Hédou G. F., Angelici O., Arban R., Tasan R. O., Sperk G., and, Caberlotto L., (2011) Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors. Neuroscience 176, 420-30.
81. Zhu J. P., Xu W., and, Angulo J. A., (2006) Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 140, 607-622.